Mark Greenwald to Analgesics, Opioid
This is a "connection" page, showing publications Mark Greenwald has written about Analgesics, Opioid.
Connection Strength
0.654
-
Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder. Am J Emerg Med. 2019 12; 37(12):2259-2262.
Score: 0.428
-
A Neuropharmacological Model to Explain Buprenorphine Induction Challenges. Ann Emerg Med. 2022 12; 80(6):509-524.
Score: 0.134
-
48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method. J Addict Med. 2023 Mar-Apr 01; 17(2):233-236.
Score: 0.034
-
Synergistic Effect of Ketamine and Buprenorphine Observed in the Treatment of Buprenorphine Precipitated Opioid Withdrawal in a Patient With Fentanyl Use. J Addict Med. 2022 Jul-Aug 01; 16(4):483-487.
Score: 0.032
-
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2019 02 23; 393(10173):778-790.
Score: 0.026